BNP Paribas Financial Markets
JSPR icon

BNP Paribas Financial Markets’s Jasper Therapeutics JSPR Stock Holding History

BNP Paribas Financial Markets’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124 Hold
141
– – ﹤0.01% 5662
2025
Q4 		$258 Hold
141
– – ﹤0.01% 5543
2025
Q3 		$336 Sell
141
-140
-50% -$425 ﹤0.01% 5340
2025
Q2 		$1.56K Sell
281
-14,527
-98% -$71.5K ﹤0.01% 5103
2025
Q1 		$63.7K Buy
14,808
+11,920
+413% +$79.3K ﹤0.01% 4206
2024
Q4 		$61.7K Buy
2,888
+376
+15% +$7.83K ﹤0.01% 4341
2024
Q3 		$47.3K Buy
2,512
+1,698
+209% +$33.8K ﹤0.01% 3620
2024
Q2 		$18.5K Buy
+814
New +$19.5K ﹤0.01% 3652

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BNP Paribas Financial Markets's JSPR Position: Q1 2026 in Review

BNP Paribas Financial Markets held its Jasper Therapeutics (JSPR) position steady in Q1 2026 at 141 shares worth $124. The position accounts for ﹤0.01% of the portfolio, ranked #5662.

BNP Paribas Financial Markets first reported a position in JSPR in Q2 2024 and has held it in 8 quarters since. The position peaked at $63.7K in Q1 2025. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • BNP Paribas Financial Markets held 141 shares of Jasper Therapeutics worth $124 as of Q1 2026.
  • BNP Paribas Financial Markets left its Jasper Therapeutics share count unchanged in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5662 holding.
  • BNP Paribas Financial Markets first reported a position in Jasper Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Jasper Therapeutics position peaked at $63.7K in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.